c-Myc suppression of miR-23a/b enhances mitochondrial glutaminase expression and glutamine metabolism
Open accessThe DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Abstract
Altered glucose metabolism in cancer cells is termed the Warburg effect, which describes the propensity of most cancer cells to take up glucose avidly and convert it primarily to lactate, despite available oxygen. Notwithstanding the renewed interest in the Warburg effect, cancer cells also depend on continued mitochondrial function for metabolism, specifically glutaminolysis that catabolizes glutamine to generate ATP and lactate. Glutamine, which is highly transported into proliferating cells, is a major source of energy and nitrogen for biosynthesis, and a carbon substrate for anabolic processes in cancer cells, but the regulation of glutamine metabolism is not well understood. Here we report that the c-Myc (hereafter referred to as Myc) oncogenic transcription factor, which is known to regulate microRNAs and stimulate cell proliferation, transcriptionally represses miR-23a and miR-23b, resulting in greater expression of their target protein, mitochondrial glutaminase, in human P-493 B lymphoma cells and PC3 prostate cancer cells. This leads to upregulation of glutamine catabolism. Glutaminase converts glutamine to glutamate, which is further catabolized through the tricarboxylic acid cycle for the production of ATP or serves as substrate for glutathione synthesis. The unique means by which Myc regulates glutaminase uncovers a previously unsuspected link between Myc regulation of miRNAs, glutamine metabolism, and energy and reactive oxygen species homeostasis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Similarly, checkpoint kinase 1 (CHK1) inhibitors625–627 and glutaminase (GLS) inhibitors628–634 are also considered potential candidates for treating Myc-overexpressing cancers.”
From Recent advances in targeting the “undruggable” proteins: from drug discovery to clinical trials (2023) · cites this paper as [629]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“MYC-driven cancer cells exhibit enhanced glutamine utilization accompanied by increased expression of key glutaminolysis enzymes, including GLS1/GLS2 and GLUD1178–180.”
From Glutamine reliance in cell metabolism (2020) · cites this paper as [178]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“This was not due to increased protein levels of GLS or c-Myc, which regulates GLS expression”
From Transaminase Inhibition by 2-Hydroxyglutarate Impairs Glutamate Biosynthesis and Redox Homeostasis in Glioma (2018) · cites this paper as Gao et al., 2009
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“genes involved in glutamine metabolism appear to be under both the direct and indirect transcriptional control of the MYC protein (32, 33)”
From Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation (2009) · cites this paper as [33]
The cited source says what the claim attributes to it.
In the citing paper
“It has long been established that Myc activation upregulates glutamine metabolism [79,80], increasing glutamine flux by upregulating the glutamine transporter (ASCT2) and glutaminase-1, thus increasing glutamine conversion to glutamate [81].”
From HIF-1-Independent Mechanisms Regulating Metabolic Adaptation in Hypoxic Cancer Cells (2021) · cites this paper as [79]
2 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A Mammalian microRNA Expression Atlas Based on Small RNA Library Sequencing
Landgraf, P., Rusu, M., Sheridan, R., Sewer, A., Iovino, N., Aravin, A., Pfeffer, S., Rice, A., Kamphorst, A. O., Landthaler, M., et al. (2007) · Cell · doi:10.1016/j.cell.2007.04.040 · Cited by 3,626
DeBerardinis, R. J., Mancuso, A., Daikhin, E., Nissim, I., Yudkoff, M., Wehrli, S., & Thompson, C. B. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0709747104 · Cited by 2,622
c-Myc-regulated microRNAs modulate E2F1 expression
O'Donnell, K. A., Wentzel, E. A., Zeller, K. I., Dang, C. V., & Mendell, J. T. (2005) · Nature · doi:10.1038/nature03677 · Cited by 2,347
Self-citationTumor cell metabolism: cancer's Achilles' heel
Kroemer, G., & Pouyssegur, J. (2008) · Cancer Cell · doi:10.1016/j.ccr.2008.05.005 · Cited by 2,337
Widespread microRNA repression by Myc contributes to tumorigenesis
Chang, T.-C., Yu, D., Lee, Y.-S., Wentzel, E. A., Arking, D. E., West, K. M., Dang, C. V., Thomas-Tikhonenko, A., & Mendell, J. T. (2008) · Nature Genetics · doi:10.1038/ng.2007.30 · Cited by 1,325
Self-citationYates, J. R., Eng, J. K., McCormack, A. L., & Schieltz, D. (1995) · Analytical Chemistry · doi:10.1021/ac00104a020 · Cited by 1,253
Evidence that glutamine, not sugar, is the major energy source for cultured HeLa cells.
Reitzer, L. J., Wice, B. M., & Kennell, D. (1979) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)30124-2 · Cited by 1,240
Brick by brick: metabolism and tumor cell growth
DeBerardinis, R. J., Sayed, N., Ditsworth, D., & Thompson, C. B. (2008) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2008.02.003 · Cited by 1,018
Eilers, M., & Eisenman, R. N. (2008) · Genes & Development · doi:10.1101/gad.1712408 · Cited by 927
MicroRNA Expression Profiling in Prostate Cancer
Porkka, K. P., Pfeiffer, M. J., Waltering, K. K., Vessella, R. L., Tammela, T. L. J., & Visakorpi, T. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-0533 · Cited by 899
Cited by
Items 601–700 of 1,006
MicroRNAs Regulate Mitochondrial Function in Cerebral Ischemia-Reperfusion Injury
Hu, Y. H., Deng, H., Xu, S., & Zhang, J. (2015) · International Journal of Molecular Sciences · doi:10.3390/ijms161024895 · Cited by 87
The autophagy conundrum in cancer: influence of tumorigenic metabolic reprogramming
Eng, C. H., & Abraham, R. T. (2011) · Oncogene · doi:10.1038/onc.2011.220 · Cited by 85
Zwaans, B. M. M., & Lombard, D. B. (2014) · Disease Models & Mechanisms · doi:10.1242/dmm.016287 · Cited by 92
MYC Rules: Leading Glutamine Metabolism toward a Distinct Cancer Cell Phenotype
Tambay, V., Raymond, V., & Bilodeau, M. (2021) · Cancers · doi:10.3390/cancers13174484 · Cited by 95
miRNAs link metabolic reprogramming to oncogenesis
Hatziapostolou, M., Polytarchou, C., & Iliopoulos, D. (2013) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2013.03.002 · Cited by 90
A therapeutic role for targeting c-Myc/Hif-1- dependent signaling pathways
Podar, K., & Anderson, K. C. (2010) · Cell Cycle · doi:10.4161/cc.9.9.11358 · Cited by 81
Mitochondrial Flexibility of Breast Cancers: A Growth Advantage and a Therapeutic Opportunity
Avagliano, A., Ruocco, M. R., Aliotta, F., Belviso, I., Accurso, A., Masone, S., Montagnani, S., & Arcucci, A. (2019) · Cells · doi:10.3390/cells8050401 · Cited by 93
Myc promotes glutaminolysis in human neuroblastoma through direct activation of glutaminase 2
Xiao, D., Ren, P., Su, H., Yue, M., Xiu, R., Hu, Y., Liu, H., & Qing, G. (2015) · Oncotarget · doi:10.18632/oncotarget.5821 · Cited by 80
“Multiple signaling pathways, including c-Myc, NF-κB and RAF, activate GLS1 induction in human cancer cells [15, 23, 30].”
BackgroundResultThe mitochondrial genome in aging and senescence
Lauri, A., Pompilio, G., & Capogrossi, M. C. (2014) · Ageing Research Reviews · doi:10.1016/j.arr.2014.07.001 · Cited by 80
“Down-regulation of GLS produces a eficit in ATP production and an increase in ROS (Amores-Sanchez nd Medina, 1999; Gao et al., 2009).”
BackgroundShao, Y., Ye, G., Ren, S., Piao, H., Zhao, X., Lu, X., Wang, F., Ma, W., Li, J. X., Yin, P., et al. (2018) · International Journal of Cancer · doi:10.1002/ijc.31313 · Cited by 89
Metabolic traits of cancer stem cells
Peixoto, J., & Lima, J. (2018) · Disease Models & Mechanisms · doi:10.1242/dmm.033464 · Cited by 80
Dysregulation of Glucose Metabolism by Oncogenes and Tumor Suppressors in Cancer Cells
Marbaniang, C., & Kma, L. (2018) · PubMed · doi:10.22034/apjcp.2018.19.9.2377 · Cited by 79
Teng, R., Liu, Z., Tang, H., Zhang, W., Chen, Y., Xu, R., Chen, L., Song, J., Liu, X., & Deng, H. (2019) · Redox Biology · doi:10.1016/j.redox.2019.101218 · Cited by 79
Casciano, J. C., Perry, C. E., Cohen-Nowak, A. J., Miller, K. D., Voorde, J. V., Zhang, Q., Chalmers, S., Sandison, M. E., Liu, Q., Hedley, A., et al. (2020) · British Journal of Cancer · doi:10.1038/s41416-019-0711-3 · Cited by 87
Crosstalks of GSK3 signaling with the mTOR network and effects on targeted therapy of cancer
Evangelisti, C., Chiarini, F., Paganelli, F., Marmiroli, S., & Martelli, A. M. (2019) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2019.118635 · Cited by 93
Mitochondrial miRNA (MitomiR): a new player in cardiovascular health
Hemalatha, S., & Das, S. (2015) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/cjpp-2014-0500 · Cited by 84
MicroRNA-29B (mir-29b) regulates the Warburg effect in ovarian cancer by targeting AKT2 and AKT3
Teng, Y., Zhang, Y., Qu, K., Yang, X., Fu, J., Chen, W., & Li, X. (2015) · Oncotarget · doi:10.18632/oncotarget.5695 · Cited by 79
Bhatia, B., Hsieh, M., Kenney, A. M., & Nahle, Z. A. (2010) · Oncogene · doi:10.1038/onc.2010.454 · Cited by 86
Side Effects of Long‐Term Glutamine Supplementation
Holeček, M. (2012) · Journal of Parenteral and Enteral Nutrition · doi:10.1177/0148607112460682 · Cited by 86
Romero‐Gómez, M., Jover‐Cobos, M., Campo, J. A. D., Royo, J. L., Hoyas, E., Galán, J. J., Montoliu, C., Baccaro, E., Guevara, M., Córdoba, J., et al. (2010) · Annals of Internal Medicine · doi:10.7326/0003-4819-153-5-201009070-00002 · Cited by 79
CD47 Receptor Globally Regulates Metabolic Pathways That Control Resistance to Ionizing Radiation
Miller, T. W., Soto‐Pantoja, D. R., Schwartz, A. L., Sipes, J. M., DeGraff, W., Ridnour, L. A., Wink, D. A., & Roberts, D. D. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.665752 · Cited by 84
Androgen-regulated metabolism and biosynthesis in prostate cancer
Barfeld, S. J., Itkonen, H. M., Urbanucci, A., & Mills, I. G. (2014) · Endocrine Related Cancer · doi:10.1530/erc-13-0515 · Cited by 89
Elhammali, A., Ippolito, J. E., Collins, L., Crowley, J., Marasa, J., & Piwnica-Worms, D. (2014) · Cancer Discovery · doi:10.1158/2159-8290.cd-13-0572 · Cited by 77
Xu, L., Yin, Y., Li, Y., Chen, X., Chang, Y., Zhang, H., Liu, J., Beasley, J., McCaw, P., Zhang, H., et al. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2012748118 · Cited by 87
Dafni, H., Larson, P. E. Z., Hu, S., Yoshihara, H. A. I., Ward, C. S., Venkatesh, H. S., Wang, C., Zhang, X., Vigneron, D. B., & Ronen, S. M. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-0883 · Cited by 78
Targeting Metabolism to Induce Cell Death in Cancer Cells and Cancer Stem Cells
Pecqueur, C., Oliver, L., Oizel, K., Lalier-Bretaudeau, L., & Vallette, F. M. (2013) · International Journal of Cell Biology · doi:10.1155/2013/805975 · Cited by 92
Cai, S., Chen, R., Li, X., Cai, Y., Ye, Z., Li, S., Li, J., Huang, H., Peng, S., Wang, J., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.2880 · Cited by 76
Innovation in metabolomics to improve personalized healthcare
Cacciatore, S., & Loda, M. (2015) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.12775 · Cited by 76
Exploiting tumor metabolism: challenges for clinical translation
Vander Heiden, M. G. (2013) · Journal of Clinical Investigation · doi:10.1172/jci72391 · Cited by 76
Cao, Y., Lin, S., Wang, Y., Chin, Y. E., Kang, L., & Mi, J. (2017) · Theranostics · doi:10.7150/thno.18992 · Cited by 88
Weighing In on mTOR Complex 2 Signaling: The Expanding Role in Cell Metabolism
Luo, Y., Xu, W., Li, G., & Cui, W. (2018) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2018/7838647 · Cited by 75
Yang, J., Lin, P., Yang, M., Liu, W. C., Fu, X., Liu, D., Tao, L., Huo, Y., Zhang, J., Hua, R., et al. (2021) · Genome biology · doi:10.1186/s13059-020-02222-w · Cited by 80
MYC and KRAS cooperation: from historical challenges to therapeutic opportunities in cancer
Casacuberta‐Serra, S., González-Larreategui, Í., Capitán-Leo, D., & Soucek, L. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01907-z · Cited by 100
MicroRNAs as regulators of mitochondrial function: Role in cancer suppression
Tomasetti, M., Neužil, J., & Dong, L. (2013) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2013.09.002 · Cited by 80
Lkb1 deficiency confers glutamine dependency in polycystic kidney disease
Flowers, E., Sudderth, J., Zacharias, L. G., Mernaugh, G., Zent, R., DeBerardinis, R. J., & Carroll, T. J. (2018) · Nature Communications · doi:10.1038/s41467-018-03036-y · Cited by 81
A microRNA’s journey to the center of the mitochondria
Macgregor-Das, A. M., & Das, S. (2018) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00714.2017 · Cited by 82
Mitochondrial remodeling in cancer metabolism and survival: Potential for new therapies
Barbosa, I. A., Machado, N. G., Skildum, A. J., Scott, P. M., & Oliveira, P. J. (2012) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2012.04.005 · Cited by 95
Pinweha, P., Rattanapornsompong, K., Charoensawan, V., & Jitrapakdee, S. (2016) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2016.05.005 · Cited by 75
ncRNAs: New Players in Mitochondrial Health and Disease?
Gušić, M., & Prokisch, H. (2020) · Frontiers in Genetics · doi:10.3389/fgene.2020.00095 · Cited by 75
Kinetic characterization of ebselen, chelerythrine and apomorphine as glutaminase inhibitors
Thomas, A. G., Rojas, C., Tanega, C., Shen, M., Simeonov, A., Boxer, M. B., Auld, D. S., Ferraris, D. V., Tsukamoto, T., & Slusher, B. S. (2013) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2013.06.110 · Cited by 73
A microenvironment-mediated c-Myc/miR-548m/HDAC6 amplification loop in non-Hodgkin B cell lymphomas
Lwin, T., Zhao, X., Cheng, F., Zhang, X., Huang, A., Shah, B. D., Zhang, Y., Moscinski, L. C., Choi, Y. S., Kozikowski, A. P., et al. (2013) · Journal of Clinical Investigation · doi:10.1172/jci64210 · Cited by 79
Xu, R., Yang, J., Ren, B., Wang, H., Yang, G., Chen, Y., You, L., & Zhao, Y. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.572722 · Cited by 78
Side Effects of Amino Acid Supplements
Holeček, M. (2022) · Physiological Research · doi:10.33549/physiolres.934790 · Cited by 96
Tumor microenvironmental nutrients, cellular responses, and cancer
Lobel, G. P., Jiang, Y., & Simon, M. C. (2023) · Cell chemical biology · doi:10.1016/j.chembiol.2023.08.011 · Cited by 88
Noncoding RNAs: New Players in Cancers
Chen, X., Fan, S., & Song, E. (2016) · Advances in experimental medicine and biology · doi:10.1007/978-981-10-1498-7_1 · Cited by 80
The miR-17∼92 microRNA Cluster Is a Global Regulator of Tumor Metabolism
Izreig, S., Samborska, B., Johnson, R. M., Sergushichev, A., Ma, E. H., Lussier, C. R., Loginicheva, E., Donayo, A. O., Poffenberger, M. C., Sagan, S. M., et al. (2016) · Cell Reports · doi:10.1016/j.celrep.2016.07.036 · Cited by 88
MicroRNA regulation of K-Ras in pancreatic cancer and opportunities for therapeutic intervention
Karmakar, S., Kaushik, G., Nimmakayala, R. K., Rachagani, S., Ponnusamy, M. P., & Batra, S. K. (2017) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2017.11.020 · Cited by 78
Understanding the non-canonical pathways involved in p53-mediated tumor suppression
Hager, K. M., & Gu, W. (2013) · Carcinogenesis · doi:10.1093/carcin/bgt487 · Cited by 78
Hanaford, A. R., Alt, J., Rais, R., Wang, S. Z., Kaur, H., Thorek, D. L. J., Eberhart, C. G., Slusher, B. S., Martin, A. M., & Raabe, E. H. (2019) · Translational Oncology · doi:10.1016/j.tranon.2019.05.013 · Cited by 79
Banerjee, S., Ghosh, S., Mandal, A., Ghosh, N., & Sil, P. C. (2020) · Archives of Toxicology · doi:10.1007/s00204-020-02801-7 · Cited by 76
Inhibition of glutaminolysis in combination with other therapies to improve cancer treatment
Shen, Y., Chen, C., Huang, Y., Evans, E. E., Cheng, C., Chuang, Y.-J., Zhang, C., & Le, A. (2021) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2021.01.006 · Cited by 79
The impact of MYC expression in lymphoma biology: Beyond Burkitt lymphoma
Smith, S. M., Anastasi, J., Cohen, K. S., & Godley, L. A. (2010) · Blood Cells Molecules and Diseases · doi:10.1016/j.bcmd.2010.08.002 · Cited by 78
Anderton, B., Camarda, R., Balakrishnan, S., Balakrishnan, A., Kohnz, R. A., Lim, L., Evason, K. J., Momcilovic, O., Kruttwig, K., Huang, Q., et al. (2017) · EMBO reports · doi:10.15252/embr.201643068 · Cited by 74
Deregulated transcription factors in cancer cell metabolisms and reprogramming
Kant, R., Manne, R., Anas, M., Penugurti, V., Chen, T., Pan, B., Hsu, C.-C., & Lin, H. (2022) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2022.10.001 · Cited by 81
Perera, R. M., & Bardeesy, N. M. (2011) · Nature · doi:10.1038/475043a · Cited by 82
Micro RNA s and lymphomagenesis: a functional review
Lawrie, C. H. (2012) · British Journal of Haematology · doi:10.1111/bjh.12157 · Cited by 82
Zhang, Y., Han, J., Liang, X., Li, Z., Zhang, F., Rasouli, J., Wang, Z., Zhang, G., & Li, X. (2017) · Molecular Therapy · doi:10.1016/j.ymthe.2017.11.013 · Cited by 74
Ye, J., Huang, Q., Xu, J., Huang, J., Wang, J., Zhong, W., Chen, W., Lin, X., & Lin, X. (2018) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-018-2605-9 · Cited by 73
Vazquez, A., & Oltvai, Z. N. (2011) · PLoS ONE · doi:10.1371/journal.pone.0019538 · Cited by 70
Goto, M., Miwa, H., Shikami, M., Tsunekawa-Imai, N., Suganuma, K., Mizuno, S., Takahashi, M., Mizutani, M., Hanamura, I., & Nitta, M. (2014) · Cancer Investigation · doi:10.3109/07357907.2014.907419 · Cited by 70
Kuo, M. T., Chen, H., Feun, L. G., & Savaraj, N. (2021) · Pharmaceuticals · doi:10.3390/ph14010072 · Cited by 87
Glutathione-Dependent Pathways in Cancer Cells
Kalinina, E. V. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25158423 · Cited by 88
c-Myc modulates microRNA processing via the transcriptional regulation of Drosha
Wang, X., Zhao, X., Gao, P., & Wu, M. (2013) · Scientific Reports · doi:10.1038/srep01942 · Cited by 83
Self-citationDiet, MicroRNAs and Prostate Cancer
Saini, S., Majid, S., & Dahiya, R. (2010) · Pharmaceutical Research · doi:10.1007/s11095-010-0086-x · Cited by 74
The MYC mRNA 3′‐UTR couples RNA polymerase II function to glutamine and ribonucleotide levels
Dejure, F. R., Royla, N., Herold, S., Kalb, J., Walz, S., Ade, C. P., Mastrobuoni, G., Vanselow, J. T., Schlosser, A., Wolf, E., et al. (2017) · The EMBO Journal · doi:10.15252/embj.201796662 · Cited by 71
Imaging Cancer Metabolism: Underlying Biology and Emerging Strategies
Pantel, A. R., Ackerman, D., Lee, S., Mankoff, D. A., & Gade, T. P. F. (2018) · Journal of Nuclear Medicine · doi:10.2967/jnumed.117.199869 · Cited by 78
Gan, L., Xiu, R., Ren, P., Yue, M., Su, H., Guo, G., Xiao, D., Yu, J., Jiang, H., Liu, H., et al. (2015) · Oncogene · doi:10.1038/onc.2015.360 · Cited by 73
Role of tyrosine phosphorylation in modulating cancer cell metabolism
Taddei, M. L., Pardella, E., Pranzini, E., Raugei, G., & Paoli, P. D. (2020) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2020.188442 · Cited by 74
Crosstalk between metabolism and cell death in tumorigenesis
Yang, S., Hu, C., Chen, X., Tang, Y., Li, J., Yang, H., Yang, Y., Ying, B., Xiao, X., Li, S., et al. (2024) · Molecular Cancer · doi:10.1186/s12943-024-01977-1 · Cited by 77
Carbon Source Metabolism and Its Regulation in Cancer Cells
Yin, C., Qie, S., & Sang, N. (2012) · Critical Reviews in Eukaryotic Gene Expression · doi:10.1615/critreveukargeneexpr.v22.i1.20 · Cited by 75
Design and evaluation of novel glutaminase inhibitors
McDermott, L. A., Iyer, P. C., Vernetti, L., Rimer, S., Sun, J., Boby, M. L., Yang, T., Fioravanti, M., O’Neill, J., Wang, L., et al. (2016) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2016.03.009 · Cited by 72
Hoerner, C. R., Chen, V. J., & Fan, A. C. (2019) · Kidney Cancer · doi:10.3233/kca-180043 · Cited by 68
Dong, W., Keibler, M. A., & Stephanopoulos, G. N. (2017) · Metabolic Engineering · doi:10.1016/j.ymben.2017.02.002 · Cited by 74
Zhao, X., Petrashen, A. P., Sanders, J. A., Peterson, A. L., & Sedivy, J. M. (2019) · Aging Cell · doi:10.1111/acel.12947 · Cited by 72
GLS2 is protumorigenic in breast cancers
Dias, M. M., Adamóski, D., dos Reis, L. M., Ascenção, C. F. R., de Oliveira, K. R. S., Mafra, A. C. P., Bastos, A. C. D. S., Quintero, M., Cassago, C. A. D. G., Ferreira, I. M., et al. (2019) · Oncogene · doi:10.1038/s41388-019-1007-z · Cited by 71
Neitzel, C., Demuth, P., Wittmann, S., & Fahrer, J. (2020) · Cancers · doi:10.3390/cancers12071731 · Cited by 74
Li, X., Zhu, H., Sun, W., Yang, X., Nie, Q. H., & Fang, X. (2021) · Cancer Cell International · doi:10.1186/s12935-021-02121-5 · Cited by 75
Taking on Challenging Targets: Making MYC Druggable
Horiuchi, D., Anderton, B., & Goga, A. (2014) · American Society of Clinical Oncology Educational Book · doi:10.14694/edbook_am.2014.34.e497 · Cited by 68
The metabolic cooperation between cells in solid cancer tumors
Icard, P., Kafara, P., Steyaert, J., Schwartz, L. H., & Lincet, H. (2014) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2014.06.002 · Cited by 87
Balancing biosynthesis and bioenergetics: metabolic programs in oncogenesis
Barger, J. F., & Plas, D. R. (2010) · Endocrine-Related Cancer · doi:10.1677/erc-10-0106 · Cited by 68
Saqcena, M., Mukhopadhyay, S., Hosny, C., Alhamed, A., Chatterjee, A., & Foster, D. A. (2015) · Oncogene · doi:10.1038/onc.2014.207 · Cited by 67
Control of cell metabolism by the epidermal growth factor receptor
Orofiamma, L. A., Vural, D., & Antonescu, C. N. (2022) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2022.119359 · Cited by 81
Mitochondria and Oxidative Stress in the Cardiorenal Metabolic Syndrome
Aroor, A. R., Mandavia, C., Ren, J., Sowers, J. R., & Pulakat, L. (2012) · Cardiorenal Medicine · doi:10.1159/000335675 · Cited by 67
PKM2 Tyrosine Phosphorylation and Glutamine Metabolism Signal a Different View of the Warburg Effect
Dang, C. V. (2009) · Science Signaling · doi:10.1126/scisignal.297pe75 · Cited by 71
Self-citationElgort, M., O'Shea, J. M., Jiang, Y., & Ayer, D. E. (2010) · Genes & Cancer · doi:10.1177/1947601910389604 · Cited by 76
Nutrients and the microenvironment to feed a T cell army
Johnson, M. O., Siska, P. J., Contreras, D. C., & Rathmell, J. C. (2016) · Seminars in Immunology · doi:10.1016/j.smim.2016.09.003 · Cited by 67
EMT-induced metabolite signature identifies poor clinical outcome
Bhowmik, S. K., Ramirez‐Peña, E., Arnold, J. M., Putluri, V., Sphyris, N., Michailidis, G. C., Putluri, N., Ambs, S., Sreekumar, A., & Mani, S. A. (2015) · Oncotarget · doi:10.18632/oncotarget.4765 · Cited by 71
Lee, S. Y., Ju, M. K., Jeon, H. M., Lee, Y. J., Kim, C. H., Park, H. G., Han, S. I., & Kang, H. S. (2018) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2018/1027453 · Cited by 71
Self-citationGLS1 promotes proliferation in hepatocellular carcinoma cells via AKT/GSK3β/CyclinD1 pathway
Xi, J., Sun, Y., Zhang, M., Fa, Z., Wan, Y.-Y., Min, Z., Xu, H., Xu, C., & Tang, J. (2019) · Experimental Cell Research · doi:10.1016/j.yexcr.2019.04.005 · Cited by 78
Grinde, M. T., Hilmarsdóttir, B., Tunset, H. M., Henriksen, I. M., Kim, J., Haugen, M. H., Rye, M. B., Mælandsmo, G. M., & Moestue, S. A. (2019) · Breast Cancer Research · doi:10.1186/s13058-019-1141-0 · Cited by 70
The structure and allosteric regulation of glutamate dehydrogenase
Li, M., Li, C., Allen, A., Stanley, C. A., & Smith, T. J. (2011) · Neurochemistry International · doi:10.1016/j.neuint.2010.10.017 · Cited by 65
Non-coding RNAs: the cancer genome dark matter that matters!
Ling, H. Y., Girnita, L., Buda, O., & Călin, G. A. (2016) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm-2016-0740 · Cited by 69
Molecular targeting of glutaminase sensitizes ovarian cancer cells to chemotherapy
Masamha, C. P., & LaFontaine, P. R. (2018) · Journal of Cellular Biochemistry · doi:10.1002/jcb.26814 · Cited by 71
Guo, W., Tan, H., Chen, F., Wang, N., & Feng, Y. (2020) · Cancers · doi:10.3390/cancers12020404 · Cited by 66
A second Warburg‐like effect in cancer metabolism: The metabolic shift of glutamine‐derived nitrogen
Kodama, M., & Nakayama, K. I. (2020) · BioEssays · doi:10.1002/bies.202000169 · Cited by 73
Natsumeda, M., Igarashi, H., Nomura, T., Ogura, R., Tsukamoto, Y., Kobayashi, T., Aoki, H., Okamoto, K., Kakita, A., Takahashi, H., et al. (2014) · Acta Neuropathologica Communications · doi:10.1186/s40478-014-0158-y · Cited by 68
Hyperpolarized 13C MR for Molecular Imaging of Prostate Cancer
Wilson, D. M., & Kurhanewicz, J. V. (2014) · Journal of Nuclear Medicine · doi:10.2967/jnumed.114.141705 · Cited by 67
Myc-mediated SDHA acetylation triggers epigenetic regulation of gene expression and tumorigenesis
Li, S., Huang, D., Shen, S., Cai, Y., Xing, S., Wu, G., Jiang, Z., Hao, Y., Yuan, M., Wang, N., et al. (2020) · Nature Metabolism · doi:10.1038/s42255-020-0179-8 · Cited by 76
Self-citationGhergurovich, J. M., Lang, J. D., Levin, M. K., Briones, N., Facista, S. J., Mueller, C., Cowan, A. J., McBride, M. J., San Roman Rodriguez, E., Killian, A., et al. (2021) · Med · doi:10.1016/j.medj.2021.03.009 · Cited by 62
Oxygen in the regulation of intestinal epithelial transport
Ward, J. B. J., Keely, S., & Keely, S. J. (2014) · The Journal of Physiology · doi:10.1113/jphysiol.2013.270249 · Cited by 75
Metadata
- Authors
- Gao, P., Tchernyshyov, I., Chang, T.-C., Lee, Y.-S., Kita, K., Ochi, T., Zeller, K. I., De Marzo, A. M., Van Eyk, J. E., Mendell, J. T., & Dang, C. V.
- Affiliations
- Johns Hopkins University (US)
- Teikyo University (JP)
- Corresponding author
- Gao, Ping
- Dang, Chi V.
- Venue
- Nature
- Published
- 2009-02-15
- Volume
- 458
- Issue
- 7239
- Pages
- 762-765
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- PMC
- PMC2729443
- OpenAlex
- W2074873270
- Cited by
- 2,124
- References
- 30
- Citations by year
- 2026: 50 · 2025: 85 · 2024: 105 · 2023: 138 · 2022: 131 · 2021: 142 · 2020: 158 · 2019: 146 · 2018: 146 · 2017: 134 · 2016: 126 · 2015: 145 · 2014: 161 · 2013: 125 · 2012: 144
- FWCI
- 37.03
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Institutional Repositories DataBase (IRDB) (submittedVersion)
- Funders
- National Institutes of Health (n01hv28180-13-0-0)
- National Heart, Lung, and Blood Institute (N01 HV-28180, N01 HV028180, R01HL085434)
- National Cancer Institute (R01 CA57341, R01CA057341, R01CA120185, P50CA058236, R37CA051497, P50-CA58236, R01CA051497)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › MicroRNA in disease regulation
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Amino Acid Enzymes and Metabolism
- Keywords
- c-Myc, miR-23a, miR-23b, glutamine metabolism, glutaminolysis, microRNA regulation, cancer metabolism, Warburg effect, PC-3 cells, reactive oxygen species, glutathione synthesis
- MeSH terms
- Glutaminase, Glutamine, Humans, Mitochondria, Gene Expression Regulation, Enzymologic, Proto-Oncogene Proteins c-myc, 3' Untranslated Regions, MicroRNAs, Cell Line, Tumor
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.